We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+8.26%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$183M
AUM Growth
+$16.5M
Cap. Flow
+$4.95M
Cap. Flow %
2.71%
Top 10 Hldgs %
70.41%
Holding
624
New
37
Increased
151
Reduced
119
Closed
30

Top Buys

Rank Stock Value
1
FNA
Paragon 28, Inc.
FNA
+$3.19M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$908K
3
NVDA icon
NVIDIA
NVDA
+$764K
4
EVH icon
Evolent Health
EVH
+$528K
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$399K

Top Sells

Rank Stock Value
1
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$431K
2
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$417K
3
IWM icon
iShares Russell 2000 ETF
IWM
+$337K
4
PRLB icon
Protolabs
PRLB
+$293K
5
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$176K

Sector Composition

Rank Sector Weight
1 Healthcare 13.01%
2 Financials 4.64%
3 Technology 4.06%
4 Industrials 1.41%
5 Consumer Discretionary 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ING icon
426
ING
ING
$92.9B
$3.67K ﹤0.01%
202
+1
+0.5% +$18
DXC icon
427
DXC Technology
DXC
$1.91B
$3.63K ﹤0.01%
175
– –
SYLD icon
428
Cambria Shareholder Yield ETF
SYLD
$1B
$3.63K ﹤0.01%
+50
New +$3.49K
HLN icon
429
Haleon
HLN
$45.3B
$3.57K ﹤0.01%
338
+1
+0.3% +$10
TLRY icon
430
Tilray
TLRY
$543M
$3.52K ﹤0.01%
200
– –
ZYME icon
431
Zymeworks
ZYME
$1.62B
$3.51K ﹤0.01%
280
– –
RELX icon
432
RELX
RELX
$66.7B
$3.49K ﹤0.01%
74
-28
-27% -$1.3K
AON icon
433
Aon
AON
$80.6B
$3.49K ﹤0.01%
10
– –
DD icon
434
DuPont de Nemours
DD
$18.6B
$3.46K ﹤0.01%
31
– –
OCUL icon
435
Ocular Therapeutix
OCUL
$1.83B
$3.45K ﹤0.01%
397
– –
HSY icon
436
Hershey
HSY
$37.3B
$3.45K ﹤0.01%
18
– –
GLW icon
437
Corning
GLW
$107B
$3.39K ﹤0.01%
75
– –
IXUS icon
438
iShares Core MSCI Total International Stock ETF
IXUS
$56.8B
$3.34K ﹤0.01%
46
– –
IMMR icon
439
Immersion
IMMR
$243M
$3.3K ﹤0.01%
370
+1
+0.3% +$10
CDNS icon
440
Cadence Design Systems
CDNS
$91.6B
$3.25K ﹤0.01%
12
-4
-25% -$1.11K
ICE icon
441
Intercontinental Exchange
ICE
$87.2B
$3.21K ﹤0.01%
20
– –
AMRN
442
Amarin Corp
AMRN
$297M
$3.13K ﹤0.01%
250
– –
STR
443
DELISTED
Sitio Royalties
STR
$3.1K ﹤0.01%
149
– –
ALL icon
444
Allstate
ALL
$70.6B
$3.03K ﹤0.01%
+16
New +$2.84K
LYG icon
445
Lloyds Banking Group
LYG
$85.2B
– –
-1,064
Closed -$3.19K
ALC icon
446
Alcon
ALC
$34B
$3K ﹤0.01%
30
– –
ETR icon
447
Entergy
ETR
$50.3B
$2.99K ﹤0.01%
46
– –
ARKF icon
448
ARK Blockchain & Fintech Innovation ETF
ARKF
$731M
$2.98K ﹤0.01%
100
– –
PWR icon
449
Quanta Services
PWR
$84.2B
$2.98K ﹤0.01%
10
– –
DELL icon
450
Dell
DELL
$239B
$2.96K ﹤0.01%
25
– –
16 17
18
19 20

Similar funds

IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return

HighMark Wealth Management's Q3 2024 Portfolio in Review

As of Q3 2024, HighMark Wealth Management held 624 positions worth $183M, up 9.9% from $166M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

HighMark Wealth Management's Q3 2024 filing shows 37 new, 151 increased, 119 reduced and 30 closed positions. Its largest new stake was Evolent Health: 20,475 shares worth $579K. The largest sale was Aurinia Pharmaceuticals, an estimated $431K.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q3 2024 buy was Evolent Health: 20,475 shares worth $579K.
  • HighMark Wealth Management added most to Paragon 28, Inc. in Q3 2024, an estimated $3.19M increase.
  • HighMark Wealth Management's biggest Q3 2024 reduction was Aurinia Pharmaceuticals, cutting an estimated $431K.
  • HighMark Wealth Management fully exited ProShares Short S&P500 in Q3 2024, selling an estimated $40.2K.
  • HighMark Wealth Management's ten largest holdings make up 70% of its $183M portfolio in Q3 2024.
  • HighMark Wealth Management opened 37 new positions and closed 30 in Q3 2024.
  • HighMark Wealth Management's portfolio value rose 9.9% quarter-over-quarter to $183M.

Based on HighMark Wealth Management's 13F filing for Q3 2024, filed 17 Oct 2024.